Skip to content

A Study Comparing ETHICON™ 4000 Stapler System With Standard of Care Stapling Devices in Adults Undergoing Gastric and Thoracic Procedures

A Post Market, Two-Arm, Multi-Center, Randomized Controlled Trial Comparing Clinical Outcomes Using the ETHICON™ 4000 Stapler System Versus Standard of Care Stapling Devices in Adults Undergoing Gastric and Thoracic Procedures

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07744568
Enrollment
300
Registered
2026-08-04
Start date
2026-09-16
Completion date
2028-02-28
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Procedures, Operative

Keywords

surgical stapler, endocutter, reload, staple line, sleeve gastrectomy, lung resection, prolonged air leak, bleeding, intraoperative, ETHICON 4000

Brief summary

The purpose of this study is to compare how well the ETHICON™ 4000 Stapler works as compared to the standard stapling devices by assessing how often air leaks and bleeding along the staple line occur during lung and stomach surgeries and by evaluating the side effects occurring within 30 days of surgery.

Interventions

DEVICEETHICON™ 4000 Stapler System

The Investigator will use the ETHICON™ 4000 Stapler System, as per instructions for use (IFU). This system is composed of two primary components: The ETHICON 4000 Stapler and the ETHICON 3D Reloads.

DEVICEStandard of Care Stapler and Reloads

The Investigator will choose a commercially available stapler and reload(s) per their professional preference produced by any manufacturer and aligned with the manufacturer's IFU. The only exception is that the Investigator may not use the ETHICON™ 4000 Stapler System.

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Prior to study enrollment, the participant and treating surgeon must have determined to proceed with one of the following surgical procedures as part of routine clinical care: a. A gastric procedure (sleeve gastrectomy) involving stapling of the stomach; or b. A thoracic procedure (lung resection limited to lobectomy, segmentectomy, or wedge resection) involving stapling of the lung * Willingness to give consent and comply with all study-related evaluations and visit schedule * At least 18 years of age

Exclusion criteria

* Physical or psychological condition which would impair study participation * The planned procedure is a revision/ reoperation for the same indication or same anatomical location * Trauma participants * Any condition or clinically significant finding that, in the Investigator's judgement, may interfere with study participation, impact the assessment of endpoints, or compromise the patient's safety or welfare * Any medical condition that the Investigator deems could impact inflammatory or immune response * Enrollment in a concurrent interventional clinical study that could impact the study endpoints

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal- Percentage of Firings Associated with Each Intraoperative Grade of Bleeding at the Staple LineIntraoperativePercentage of firings associated with each intraoperative grade of bleeding at the staple line (prior to prophylactic or intervention to the staple line) will be reported. The percentage of staple firings for each bleeding grade and for bleeding scores of 4 or below, 3 or below, 2 or below, 1 or below, and 0 will be estimated.
Thoracic- Percentage of Firings Associated with Intraoperative Air Leak at the Staple LineIntraoperativePercentage of firings associated with intraoperative air leak at the staple line (prior to prophylactic or intervention to the staple line) will be reported.

Secondary

MeasureTime frameDescription
Length of Hospital StayUp to 30 Days Post ProcedureNumber of days from the date of hospital admission to discharge from the hospital will be reported.
Gastrointestinal: Percentage of Participants Experiencing Gastric Leak Up to 30 Days Post-ProcedureUp to 30 Days Post ProcedurePercentage of participants experiencing gastric leak occurring up to 30 days post procedure will be reported.
Thoracic: Duration of Tube PlacementUp to 30 Days Post ProcedureDuration of chest tube placement and removal will be reported.
Thoracic: Postoperative Air Leak DurationUp to 30 Days Post ProcedurePostoperative air leak duration upon submersion test (prior to prophylactic or intervention to the staple line) using a binary determination (air leak, yes/no) will be reported.
Thoracic: Percentage of Participants with Prolonged Air Leak (PAL)Up to 30 Days Post ProcedurePAL is defined as an air leak that persists more than (\>) 5 days after the study procedure.

Contacts

CONTACTKari Loing
RA-ESC202408@its.jnj.com(513) 337-7000
STUDY_DIRECTORGianluca Casali, MD

Ethicon Endo-Surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026